|
TMEM9B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.94349999999811E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.955100E-04 |
| Normal-vs-Stage2 |
6.059800E-03 |
| Normal-vs-Stage3 |
1.039680E-04 |
| Normal-vs-Stage4 |
2.141500E-03 |
| Stage1-vs-Stage2 |
9.439200E-01 |
| Stage1-vs-Stage3 |
1.947190E-01 |
| Stage1-vs-Stage4 |
1.052960E-01 |
| Stage2-vs-Stage3 |
2.532400E-01 |
| Stage2-vs-Stage4 |
2.019800E-01 |
| Stage3-vs-Stage4 |
7.958400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37049999999295E-05 |
| Normal-vs-AfricanAmerican |
2.677600E-02 |
| Normal-vs-Asian |
2.112600E-01 |
| Caucasian-vs-AfricanAmerican |
3.476300E-02 |
| Caucasian-vs-Asian |
5.485600E-01 |
| AfricanAmerican-vs-Asian |
8.871600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.37370000000837E-05 |
| Normal-vs-Female |
1.777320E-03 |
| Male-vs-Female |
6.236400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.579810E-03 |
| Normal-vs-Extreme_Weight |
2.361900E-03 |
| Normal-vs-Obese |
4.977400E-04 |
| Normal-vs-Extreme_Obese |
1.660430E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.204400E-01 |
| Normal_Weight-vs-Obese |
9.127200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.813000E-01 |
| Extreme_Weight-vs-Obese |
7.689400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.463400E-01 |
| Obese-vs-Extreme_Obese |
6.004000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.547600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.368800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.587840E-04 |
| Normal-vs-Age(81-100Yrs) |
1.042430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.901000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.058400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.258800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.880800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.501400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.361200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.244300E-04 |
| Normal-VS-Type2 PRCC |
1.74130999999189E-05 |
| Normal-VS-KIRP CIMP |
2.860900E-03 |
| Normal-VS-Unclassified PRCC |
4.760800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.197400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.164400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.257000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.963200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.391200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.311600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1555000000163E-06 |
| Normal-vs-N1 |
4.15110000000496E-05 |
| Normal-vs-N2 |
9.896100E-03 |
| N0-vs-N1 |
8.503800E-01 |
| N0-vs-N2 |
3.514000E-01 |
| N1-vs-N2 |
3.590000E-01 |
|
|
